Myovant Sciences Ltd (NYSE:MYOV)
| 17.59 Delayed Data As of 4:00pm ET |  +0.91 / +5.46%Today’s Change | 7.67 Today|||52-Week Range 27.43 | +12.97% Year-to-Date |
Latest MYOV News | Press Releases
No recent news for Myovant Sciences Ltd.
Today’s Trading
| Previous close | 16.68 |
| Today’s open | 16.09 |
| Day’s range | 16.25 - 17.67 |
| Volume | 982,673 |
| Average volume (3 months) | 826,076 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 08/10/2022
Growth & Valuation
| Earnings growth (last year) | +21.82% |
| Earnings growth (this year) | +32.97% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +289.39% |
| P/E ratio | NM |
| Price/Sales | 5.36 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SIGASIGA Technologies In... | +0.11 | +0.48% |
| ---- | ||
| EBSEmergent BioSolution... | +0.77 | +2.59% |
| RGNXRegenxbio Inc | +0.66 | +1.94% |
Data as of 4:00pm ET, 08/10/2022
Financials
| Next reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $231.0M |
| Annual profit (last year) | -$206.0M |
| Net profit margin | -89.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
